1. HOME>
  2. 研究・実績>
  3. 研究業績

主要な研究業績

2016

1. Amano M, Hanafusa T, Chikazawa S, Ueno M, Namiki T, Igawa K, Miura K, Yokozeki H. Bazex Syndrome in Lung Squamous Cell Carcinoma: High Expression of Epidermal Growth Factor Receptor in Lesional Keratinocytes with Th2 Immune Shift. Case Rep Dermatol. 2016 Dec 8;8(3):358-362.
2. Namiki T, Tokoro S, Hanafusa T, Yokozeki H. Image Gallery: Periorbital and temporal dermal melanocytosis of hypohidrotic ectodermal dysplasia. Br J Dermatol. 2016 Dec;175(6):e146-e147.
3. Yu R, Igawa K, Handa Y, Munetsugu T, Satoh T, Yokozeki H. Basophils and mast cells are crucial for reactions due to epicutaneous sensitization to ovalbumin. Exp Dermatol. 2016 Dec 19.
4. Namiki T, Hanafusa T, Ueno M, Miura K, Yokozeki H. Severe Oral Ulcers Associated With Nivolumab Treatment. JAMA Dermatol. 2016 Dec 14. [Epub ahead of print]
5. Namiki T, Miura K, Tokoro S, Tanaka M, Yokozeki H. Dermoscopic features of lymphocytoma cutis: A case report of a representative dermoscopic feature. Dermatol. 2016 Nov;43(11):1367-1368.
6. Munetsugu T, Igawa K, Fujimoto T, Shibama S, Nishizawa A, Yokozeki H. Cold-induced hyperhidrosis: possible association with hyper-IgE syndrome. Int J Dermatol. 2016 Oct 25.
7. Kato K, Namiki T, Yokozeki H. Acquired anhidrosis in a case of autoimmune autonomic ganglionopathy. J Dermatol. 2017 Mar;44(3):e36-e37.
8. Munetsugu T, Fujimoto T, Oshima Y, Sano K, Murota H, Satoh T, Iwase S, Asahina M, Nakazato Y, Yokozeki H. Revised guideline for the diagnosis and treatment of acquired idiopathic generalized anhidrosis in Japan. J Dermatol. 2017 Apr;44(4):394-400.
9. Kato K, Igawa K, Nishizawa A, Takayama K, Yokozeki H. Allergic contact dermatitis induced by the anionic surfactant, sodium N-methyl-N-(1-oxododecyl)-beta-alaninate, contained in a daily-use shampoo. J Eur Acad Dermatol Venereol. 2016 Nov;30(11):e123-e124.
10. Chikazawa S, Hanafusa T, Ozaki K, Namiki T, Amano M, Ueno M, Tokoro S, Igawa K, Sato T, Ishikawa K, Yokota T, Yokozeki H. Incomplete Behcet's disease with calf muscle pain and MRI hyperintensity due to possible thrombophlebitis. Eur J Dermatol. 2017 Feb 1;27(1):76-77.
11. Nojima K, Namiki T, Tokoro S, Miura K, Yokozeki H. A case of nodular subungual melanoma without Hutchinson's nail sign. Australas J Dermatol. 2016 Oct 12.
12. Matsuura-Otsuki Y, Hanafusa T, Namiki T, Ueno M, Tokoro S, Igawa K, Yokozeki H. Relapsed nasal extranodal NK/T-cell lymphoma with secondary cutaneous involvement presenting as a phlegmon-like lesion. Eur J Dermatol.26(6):630-631 2016 Oct 6.
13. Chen Y, Yokozeki H, Katagiri K. Physiological and functional changes in the stratum corneum restored by estrogen in an ovariectomized mice model of climacterium. Exp Dermatol. 2016 Sep 27.
14. Yokozeki H. New Pathologies of Skin Disorders Identified from the History of Perspiration Research. Curr Probl Dermatol. 2016;51:1-6.
15. Suzuki R, Yikelamu A, Tanaka R, Igawa K, Yokozeki H, Yaguchi T. Studies in Phylogeny, Development of Rapid IdentificationMethods, Antifungal Susceptibility, and Growth Rates of Clinical Strains of Sporothrix schenckii Complex in Japan. Med Mycol J. 2016;57(3):E47-57.
16. Kato K, Namiki T, Tokoro S, Takayama K, Yokozeki H. Bullous eosinophilic annular erythema. J Dermatol. 2016 Aug 11.
17. Funazumi M, Namiki T, Arima Y, Kato K, Nojima K, Tanaka K, Miura K, Yokozeki H. Increased Infiltration of CD8(+) T Cells by Dacarbazine in a Patient with Mucosal Penile Melanoma Refractory to Nivolumab. Ann Dermatol. 2016 Aug;28(4):486-90.
18. Namiki T, Takahashi M, Nojima K, Ueno M, Hanafusa T, Tokoro S, Yokozeki H. Phakomatosis pigmentovascularis type IIb: A case with Klippel-Trenaunay syndrome and extensive dermal melanocytosis as nevus of Ota, nevus of Ito and ectopic Mongolian spots. J Dermatol. 2016 Jul 4.
19. Namiki T, Iikawa M, Otsuki Y, Ueno M, Yokozeki H. Ectopic extramammary Paget disease mimicking Bowen disease. J Am Acad Dermatol. 2016 Jul;75(1):e9-e10.
20. Hirohata A, Hanafusa T, Igawa K, Inoue-Nishimoto T, Mabuchi-Kiyohara E, Nakai C, Kasugai T, Yokozeki H, Ikegami R. Bullous erythema ab igne with cutaneous reactive angiomatosis. Eur J Dermatol. 2016 Apr 1;26(2):191-2.
21. Namiki T, Ichiyama S, Funasaka Y, Ito M, Kanzaki A, Miura K, Nojima K, Saeki H, Yokozeki H, Tanaka M. Dermoscopy of pigmented papillated Bowen disease: A report of two cases. J Dermatol. 2016 May 21.
22. Namiki T, Miura K, Nojima K, Ueno M, Tanaka K, Tanaka M, Yokozeki H. Ulcerated giant pilomatricoma with appearance of cutaneous malignancy on positron emission tomography/computed tomography. J Dermatol. 2016 May 21.
23. Inui K, Hanafusa T, Namiki T, Ueno M, Igawa K, Yokozeki H. Intractable Postoperative Wounds Caused by Self-Inflicted Trauma in a Patient with Cutaneous Munchausen Syndrome Presenting as a Pyoderma Gangrenosum-Like Lesion. Case Rep Dermatol. 2016 Apr 21;8(1):97-101.
24. Namiki T, Miura K, Ueno M, Arima Y, Nishizawa A, Yokozeki H. Four Different Tumors Arising in a Nevus Sebaceous. Case Rep Dermatol. 2016 Apr 20;8(1):75-9.
25. Kato K, Namiki T, Tokoro S, Miura K, Yokozeki H. Histiocytoid Sweet syndrome with ophthalmologic involvements: A novel association with uveitis. J Dermatol. 2016 May 14.
26. Amano M, Hanafusa T, Inui K, Nakadai T, Nojima K, Tokoro S, Namiki T, Igawa K, Miura K, Yokozeki H. Microscopic polyangiitis presenting with multiple punched-out ulcers: A case report. J Dermatol. 2016 May 14.
27. Matsuura-Otsuki Y, Hanafusa T, Namiki T, Ueno M, Inazawa M, Tokoro S, Igawa K, Nakamura M, Igari K, Inoue Y, Yokozeki H. Peripheral arterial bypass surgery for intractable wounds caused by limited cutaneous systemic sclerosis. J Dermatol. 2016 Apr 30.
28. Ugajin T, Shibama S, Nishida K, Yokozeki H. Metallothioneins are required for human basophil interleukin-4 gene induction via Fc?RΙ stimulation. Allergol Int. 2016 Apr 20.
29. Nojima K, Namiki T, Inui K, Hanafusa T, Miura K, Asakage T, Yokozeki H. Rapid reduction of nasal melanoma by nivolumab. Eur J Dermatol.26(4):405-406. 2016 Apr 21.
30. Matsuura-Otsuki Y, Hanafusa T, Igawa K, Sato H, Nishizawa A, Yokozeki H. Macrophage activation syndrome triggered by disseminated tuberculosis with tuberculous gumma in a patient with adult-onset Still's disease and Good's syndrome. Eur J Dermatol. 26(3):309-11. 2016 Mar 31.
31. Namiki T, Miura K, Ueno M, Tanaka K, Yokozeki H. Case of basal cell carcinoma with myoepithelial differentiation: Its characteristic clinical and histopathological features. J Dermatol. 43(9):1109-10. 2016 Mar 19.
32. Namiki T, Arai M, Miura K, Yokozeki H. A case of phakomatosis pigmentovascularis type II: port-wine stain and dermal melanocytosis with cutis marmorata telangiectatica congenita-like lesions. Eur J Dermatol. 26(3):302-3. 2016 Feb 24.
33. Yoshioka Y, Hanafusa T, Namiki T, Nojima K, Amano M, Tokoro S, Igawa K, Yokozeki H. Drug-induced hypersensitivity syndrome by ethambutol: A case report. J Dermatol. 43(8):971-2. 2016 Feb 19.
34. Kondo M, Igawa K, Munetsugu T, Shibama S, Nishizawa A, Tokoro S, Yokozeki H. Increasing Numbers of Mast Cells in Skin Lesions of Hyperpigmented Mycosis Fungoides with Large-Cell Transformation. Ann Dermatol. 2016 Feb;28(1):115-6.
35. Hirohata A, Hanafusa T, Igawa K, Inoue-Nishimoto T, Mabuchi-Kiyohara E, Nishide M, Yokozeki H, Ikegami R. Oral tacrolimus for the treatment of generalized morphea. Eur J Dermatol. 2016 Feb 1;26(1):112-3.
36. Arima Y, Namiki T, Kato K, Tokoro S, Takayama K, Yokozeki H. Case of extensive pyoderma gangrenosum with a neutrophilic leukemoid reaction. J Dermatol. 2016 Feb;43(2):217-8.
37. Arima Y, Namiki T, Ueno M, Kato K, Tokoro S, Takayama K, Miura K, Yokozeki H. Histiocytoid Sweet syndrome: a novel association with relapsing polychondritis. Br J Dermatol. 2016 Mar;174(3):691-4.
38. Hanafusa T, Kato K, Azukizawa H, Miyazaki J, Takeda J, Katayama I. B-1 B cell progenitors transiently and partially express keratin 5 during differentiation in bone marrow. J Dermatol Sci. 2016 Mar;81(3):173-81.
39. Sone Y, Namiki T, Munetsugu T, Ueno M, Tokoro S, Nishizawa A, Takayama K, Yokozeki H; A case of subungual melanoma with bone invasion: Destructive local invasion and multiple skin metastases. J Eur Acad Dermatol Venereol 2016: Jun 30(6):1049-1050.
40. Suzuki R, Fukuyama K, Miyazaki Y, Namiki T; Contact urricaria syndrome and protein contact dermatitis caused by glycerin enema. JAAD Case Reports 2016: Mar 2(2):108-110.

2015

1. Arima Y, Namiki T, Kato K, Ueno M, Iikawa M, Tokoro S, Takayama K, Miura K, Yokozeki H. Pigmented squamous cell carcinoma of the cheek and its dermoscopic features. J Dermatol. 2015 May 18.
2. Yamamoto T, Yokozeki H. Discoid lupus erythematosus in a patient with myasthenia gravis.  Int J Rheum Dis. 2015 May 12.
3. Ugajin T, Takahashi M, Miyagishi C, Takayama K, Yokozeki H. A case of bullous pemphigoid associated with infiltration and activation of basophils.  Br J Dermatol. 2015 Apr 27.
4. Hashimoto T, Satoh T, Yokozeki H. Protective Role of STAT6 in Basophil-Dependent Prurigo-like Allergic Skin Inflammation.  J Immunol. 2015 May 15;194(10):4631-40.
5. Namiki T, Yaguchi T, Nakamura K, Valencia JC, Coelho SG, Yin L, Kawaguchi M, Vieira WD, Kaneko Y, Tanemura A, Katayama I, Yokozeki H, Kawakami Y, Hearing VJ. NUAK2 Amplification Coupled with PTEN Deficiency Promotes Melanoma Development via CDK Activation.  Cancer Res. 2015 Apr 1.
6. Ugajin T, Nishida K, Yamasaki S, Suzuki J, Mita M, Kubo M, Yokozeki H, Hirano T. Zinc-binding metallothioneins are key modulators of IL-4 production by basophils. Mol Immunol. 2015 Aug;66(2):180-8.
7. Sone Y, Namiki T, Munetsugu T, Ueno M, Tokoro S, Nishizawa A, Takayama K, Yokozeki H. A case of subungual melanoma with bone invasion: destructive local invasion and multiple skin metastases. J Eur Acad Dermatol Venereol. 2015 Mar 12.
8. Okiyama N, Hasegawa H, Oida T, Hirata S, Yokozeki H, Fujimoto M, Miyasaka N, Kohsaka H. Experimental myositis inducible with transfer of dendritic cells presenting a skeletal muscle C protein-derived CD8 epitope peptide. Int Immunol. 2015 Jul;27(7):327-32
9. Yamamoto T, Yokozeki H. Scalp sarcoidosis mimicking organoid nevus. Eur J Dermatol. 2015 Feb 1;25(1):78-9.
10. Yamamoto T, Yokozeki H. Subcutaneous sarcoidal granuloma underlying porokeratosis in a patient with sarcoid-lymphoma syndrome. Eur J Dermatol. 2015 Feb 1;25(1):84-5.
11. Kondo T, Namiki T, Coelho SG, Valencia JC, Hearing VJ. Oculocutaneous albinism: developing novel antibodies targeting the proteins associated with OCA2 and OCA4. J Dermatol Sci. 2015 Jan;77(1):21-7.
12. Igawa K, Konishi M, Moriyama Y, Fukuyama K, Yokozeki H. Erythroderma as drug eruption induced by intravesical mitomycin C therapy. J Eur Acad Dermatol Venereol. 2015 Mar;29(3):613-4.
13. Takayama N, Nakazono S, Kumagai J, Chiorean R, Sitaru C, Ishii N, Hashimoto T, Namiki T. Pemphigoid gestationis with IgG autoantibodies to both the 120 kDa LAD-1 and the BP180 NC16a domain. Eur J Dermatol. 2015 Apr 1;25(2):190-2.

2014

1. Shibama S, Igawa K, Munetsugu T, Fukuyama K, Nishizawa A, Takayama K, Yokozeki H.:A case of sarcoidosis presenting as livedo. Ann Dermatol. 2014 Dec;26(6):773-4.
2. Dobashi K, Akiyama K, Usami A, Yokozeki H, Ikezawa Z, Tsurikisawa N, Nakamura Y, Sato K, Okumura J; Japanese Guideline for Occupational Allergic Diseases 2014. Committee for Japanese Guideline for Diagnosis and Management of Occupational Allergic Diseases; Japanese Society of Allergology. Allergol Int. 2014 Sep;63(3):421-42.
3. Yokozeki H. [The research for atopic dermatitis: up to date]. Nihon Rinsho. 2014 Aug;72(8):1503-9. Review. Japanese.
4. Nishizawa A, Igawa K, Teraki H, Yokozeki H.:Diffuse disseminated lichenoid-type cutaneous sarcoidosis mimicking erythroderma. Int J Dermatol. 53(8):e369-70. 2014
5. Igawa K, Kokubu C, Yusa K, Horie K, Yoshimura Y, Yamauchi K, Suemori H, Yokozeki H, Toyoda M, Kiyokawa N, Okita H, Miyagawa Y, Akutsu H, Umezawa A, Katayama I, Takeda J.:Removal of Reprogramming Transgenes Improves the Tissue Reconstitution Potential of Keratinocytes Generated From Human Induced Pluripotent Stem Cells. Stem Cells Transl Med. 3(9):992-1001. 2014
6. Ueno M, Aoto T, Mohri Y, Yokozeki H, Nishimura EK.:Coupling of the radiosensitivity of melanocyte stem cells to their dormancy during the hair cycle. Pigment Cell Melanoma Res. 27(4):540-51. 2014
7. Yokozeki H.:A nucleic acid-based medication for allergic skin diseases. J Dermatol Sci. 75(2):75-81. 2014
8. Nakazono S, Nojima K, Kumagai J, Hagiyama H, Yokozeki H, Namiki T.:Amicrobial pustulosis-like rash associated with systemic lupus erythematosus. J Dermatol. 41(4):359-60. 2014
9. Higuchi T, Satoh T, Yokozeki H.:Using CD40 ligand expression to detect antigen-specific T cells in patients with drug eruptions. Acta Derm Venereol. 94(1):86-7. 2014
10. Inazawa M, Satoh T, Yokozeki H.:Hyperkeratotic variant of inflammatory disseminated superficial porokeratosis with lichenoid reaction and extensive amyloid deposition. Int J Dermatol. 2014 Feb;53(2):e94-5.
11. Hashimoto T, Satoh T, Furuya A, Kataoka N, Yokozeki H.:Kimura's disease with prurigo lesions treated with systemic indomethacin. J Eur Acad Dermatol Venereol. 2014 Sep;28(9):1260-2.
12. Kato K, Hanafusa T, Igawa K, Tatsumi M, Takahashi Y, Yamanaka T, Katayama I. A rare case of annular pustular psoriasis associated with pemphigus foliaceus. Ann Dermatol. 2014 Apr;26(2):260-1.
13. Senda S, Igawa K, Nishioka M, Murota H, Katayama I. Systemic sclerosis with sarcoidosis: case report and review of the published work. J Dermatol. 2014 May;41(5):421-3.
14. Inoue T, Yamaoka T, Murota H, Yokomi A, Tanemura A, Igawa K, Tani M, Katayama I. Effective oral psoralen plus ultraviolet a therapy for digital ulcers with revascularization in systemic sclerosis. Acta Derm Venereol. 2014 Mar;94(2):250-1.
15. Nakazono S, Takayama N, Nojima K, Kumagai J, Izumi M, Namiki T. Well-differentiated syringomatous carcinoma with solid carcinoma-like features. J Dermatol. 2014 Dec;41(12):1126-7.
16. Takayama N, Nakazono S, Kumagai J, Kawamura T, Suzuki F, Ishii N, Hashimoto T, Namiki T. Case of subepidermal bullous disease with diffuse esophageal involvement presenting with immunoglobulin G autoantibodies to both the BP180 NC16a and C-terminal domains, and immunoglobulin A autoantibodies to the BP180 NC16a domain. J Dermatol. 2014 Jul;41(7):665-7.
17. Tsuji G, Okiyama N, Villarroel VA, Katz SI. Histone deacetylase 6 inhibition impairs effector CD8 T-cell functions during skin inflammation.  J Allergy Clin Immunol. 2015 May;135(5):1228-39. doi: 10.1016/j.jaci.2014.10.002.
18. Okiyama N, Katz SI. Programmed cell death 1 (PD-1) regulates the effector function of CD8 T cells via PD-L1 expressed on target keratinocytes.  J Autoimmun. 2014 Sep;53:1-9. doi: 10.1016/j.jaut.2014.06.005.
19. Oishi K, Hamaguchi Y, Matsushita T, Hasegawa M, Okiyama N, Dernedde J, Weinhart M, Haag R, Tedder TF, Takehara K, Kohsaka H, Fujimoto M. A crucial role of L-selectin in C protein-induced experimental polymyositis in mice. Arthritis Rheumatol. 2014 Jul;66(7):1864-71. doi: 10.1002/art.38630.
20. Villarroel VA, Okiyama N, Tsuji G, Linton JT, Katz SI. CXCR3-mediated skin homing of autoreactive CD8 T cells is a key determinant in murine graft-versus-host disease.  J Invest Dermatol. 2014 Jun;134(6):1552-60. doi: 10.1038/jid.2014.2.
21. Okiyama N, Furumoto Y, Villarroel VA, Linton JT, Tsai WL, Gutermuth J, Ghoreschi K, Gadina M, O'Shea JJ, Katz SI. Reversal of CD8 T-cell-mediated mucocutaneous graft-versus-host-like disease by the JAK inhibitor tofacitinib.  J Invest Dermatol. 2014 Apr;134(4):992-1000. doi: 10.1038/jid.2013.476.

2013

1. Fujimoto T, Kawahara K, Yokozeki H :Epidemiological study and considerations of primary focal hyperhidrosis in Japan: From questionnaire analysis. J Dermatol.40(11);886-890, 2013
2. Sakaguchi M, Bito T, Oda Y, Kikusawa A, Nishigori C, Munetsugu T, Yokozeki H, Itotani Y, Niguma T, Tsuruta D, Tateishi C, Ishii N, Koga H, Hashimoto T :Three cases of linear IgA/IgG bullous dermatosis showing IgA and IgG reactivity with multiple antigens, particularly laminin-332. JAMA Dermatol. 2013 Nov;149(11):1308-13.
3. Takehara Y, Satoh T, Nishizawa A, Saeki K, Nakamura M, Masuzawa M, Kaneda Y, Katayama I, Yokozeki H: Anti-tumor effects of inactivated Sendai virus particles with an IL-2 gene on angiosarcoma. Clin Immunol. 2013 Oct;149(1):1-10.
4. Tanaka K, Mori H, Okazaki M, Nishizawa A, Yokozeki H: Long-term treatment outcome after only popliteal lymph node dissection for nodal metastasis in malignant melanoma of the heel: the only "interval node" dissection can be an adequate surgical treatment. Case Rep Oncol Med. 2013;2013:259326.
5. Saeki K, Satoh T, Yokozeki H: α(1,3) Fucosyltransferases IV and VII are essential for the initial recruitment of basophils in chronic allergic inflammation. J Invest Dermatol. 2013 Sep;133(9):2161-9.
6. Kato K, Satoh T, Tanaka-Fujimoto T, Ueda N, Yokozeki H.: IgG4-positive cells in skin lesions of cutaneous and systemic plasmacytosis. Eur J Dermatol. 2013 Apr 1;23(2):255-6.
7. Kataoka N, Satoh T, Hirai A, Saeki K, Yokozeki H.:Indomethacin inhibits eosinophil migration to prostaglandin D2 : therapeutic potential of CRTH2 desensitization for eosinophilic pustular folliculitis. Immunology. 2013 Sep;140(1):78-86.
8. Inoue R, Sohara E, Rai T, Satoh T, Yokozeki H, Sasaki S, Uchida S.:Immunolocalization and translocation of aquaporin-5 water channel in sweat glands. J Dermatol Sci. 2013 Apr;70(1):26-33.
9. Takahashi E, Yokozeki H, Satoh T. Atrophic fibrous hamartoma of infancy with epidermal and adnexal changes. J Dermatol. 2013 Mar;40(3):212-4.
10. Satoh T, Ikeda H, Yokozeki H.Acrosyringeal involvement of palmoplantar lesions of eosinophilic pustular folliculitis. Acta Derm Venereol. 2013 Jan;93(1):99.
11. Inoue T, Yamaoka T, Murota H, Yokomi A, Tanemura A, Igawa K, Tani M, Katayama I. Effective Oral Psoralen Plus Ultraviolet A Therapy for Digital Ulcers with Revascularization in Systemic Sclerosis. Acta Derm Venereol. 2013 Aug 8.
12. Hanafusa T, Matsui S, Murota H, Tani M, Igawa K, Katayama I. Increased frequency of skin-infiltrating FoxP3+ regulatory T cells as a diagnostic indicator of severe atopic dermatitis from cutaneous T cell lymphoma. Clin Exp Immunol. 2013 Jun;172(3):507-12.
13. Hanafusa T, Igawa K, Kotobuki Y, Kitaba S, Tani M, Katayama I. Systemic lymphadenopathy with systemic sclerosis and Sjogren's syndrome: a case report. J Dermatol. 2013 Feb;40(2):124-5.
14. Hashimoto T, Satoh T, Furuya A, Kataoka N, Yokozeki H: Kimura’s disease with prurigo lesions treated with systemic indomethacin, J Eur Acad Dermatol Venereol, DOI: 10.1111/jdv.12339, 2013
15. Shen L, Higuchi T, Tubbe I, Voltz N, Krummen M, Pektor S, Montermann E, Rausch K, Schmidt M, Schild H, Grabbe S, Bros M. A trifunctional dextran-based nanovaccine targets and activates murine dendritic cells, and induces potent cellular and humoral immune responses in vivo. PLoS One. 2013 Dec 5;8(12)
16. Higuchi T, Satoh T, Yokozeki H. Using CD40 ligand expression to detect antigen-specific T cells in patients with drug eruptions. Acta Derm Venereol. 2014 Jan;94(1):86-7.
17. Villarroel VA, Okiyama N, Tsuji G, Linton JT, Katz SI. CXCR3-Mediated Skin Homing of Autoreactive CD8 T Cells Is a Key Determinant in Murine Graft-Versus-Host Disease. J Invest Dermatol. 2014 Jan 3.
18. Okiyama N, Furumoto Y, Villarroel VA, Linton JT, Tsai WL, Gutermuth J, Ghoreschi K, Gadina M, O'Shea JJ, Katz SI. Reversal of CD8 T-Cell-Mediated Mucocutaneous Graft-Versus-Host-Like Disease by the JAK Inhibitor Tofacitinib. J Invest Dermatol. 2013 Nov 8.
19. Miyagawa F, Okiyama N, Villarroel V, Katz SI. Identification of CD3+CD4-CD8- T cells as potential regulatory cells in an experimental murine model of graft-versus-host skin disease (GVHD). J Invest Dermatol. 2013 Nov;133(11):2538-45.

2012

1. Okiyama N, Sugihara T, Oida T, Ohata J, Yokozeki H, Miyasaka N, Kohsaka H : T lymphocytes and muscle condition act like seeds and soil in a murine polymyositis model., Arthritis Rheum, 64:3741-3749, 2012
2. Nishizawa A, Satoh T, Yokozeki H : Erythrodermic psoriasis improved by panitumumab, but not bevacizumab., Acta Derm Venereol, 92:360-361, 2012
3. Sekine R, Satoh T, Takaoka A, Saeki K, Yokozeki H : Sekine R, Satoh T, Takaoka A, Saeki K, Yokozeki H., Exp Dermatol, 21:201-204, 2012
4. Kanai Y, Satoh T, Igawa K, Yokozeki H : Impaired expression of Tim-3 on Th17 and Th1 cells in psoriasis., Acta Derm Venereol, 92:367-361, 2012
5. Oka K, Ohtaki N, Kasai S, Takayama K, Yokozeki H : Two cases of eruptive pseudoangiomatosis induced by mosquito bites., J Dermatol, 39:301-305, 2012
6. Tanaka T, Satoh T, Tanaka A, Yokozeki H : Congenital insensitivity to pain with anhidrosis: a case with preserved itch sensation to histamine and partial pain sensation., Br J Dermatol, 166:888-891, 2012
7. Yu R, Satoh T, Wakabayashi T, Ueda N, Yokozeki H : Disseminated BCG infection in severe combined immunodeficiency., Acta Derm Venereol, 92:158-159, 2012
8. Sugihara T, Okiyama N, Suzuki M, Kohyama K, Matsumoto Y, Miyasaka N, Kohsaka H : Interleukin-1 and tumor necrosis factor α blockade treatment of experimental polymyositis in mice., Arthritis and Rheumatism, 64:2655-2662, 2012
9. Hanafusa T, Igawa K, Kotobuki Y, Kitaba S, Tani M, Katayama I : Systemic lymphadenopathy with systemic sclerosis and Sjogren's syndrome: A case report., J Dermatol, 2012 Oct 18.
10. Kawaguchi M, Valencia JC, Namiki T, Suzuki T, Hearing VJ Diacylglycerol kinase regulates tyrosinase expression and function in human melanocytes. J Invest Dermatol. 2012 Dec;132(12):2791-9. 2012.
11. Kishi Y, Higuchi T, Phoon S, Sakamaki Y, Kamiya K, Riemekasten G, Akiyoshi K, Weigert MG, Tsubata T Apoptotic marginal zone deletion of anti-Sm/ribonucleoprotein B cells.Proc Natl Acad Sci U S A. 2012 May 15;109(20):7811-6.

2011

1. Igawa K, Satoh T, Yokozeki H : Possible association of Henoch-Schoenlein purpura in adults with odontogenic focal infection., Int J Dermatol, 50:277-279, 2011
2. Ito Y, Satoh T, Takayama K, Miyagishi C, Walls AF, Yokozeki H : Basophil recruitment and activation in inflammatory skin diseases., Allergy, 66:1107-1113, 2011
3. Imai A, Takayama K, Satoh T, Katoh T, Yokozeki H : Ingrown nail and pachyonychia of the great toes impair lower limb function:improvement of limb dysfunction by medical foot care treatment., Int J Dermatol, 50: 215-220, 2011
4. Ueno M, Yamamoto T, Yamanaka M, Matsunaga T : Nodular amyloidosis in a patient with liver cirrhosis., Dermatol Online J, 17:10, 2011
5. Ugajin T, Satoh T, Kanamori T, Aritake K, Urade Y, Yokozeki H: FcεRI, but not FcγR, signals induce prostaglandin D2 and E2 production from basophils ., Am J Pathol, 179:775-82, 2011
6. Okiyama N, Kitajima T, Ito Y, Yokozeki H, Miyasaka N, Kohsaka H. Addition of the collagen binding domain of fibronectin potentiates the biochemical availability of hepatocyte growth factor for cutaneous wound healing., J Dermatol, 61:215-7, 2011
7. Kato K, Satoh T, Nishizawa A, Yokozeki H : Psoriasiform drug eruption due to abatacept., Acta Derm Venereol, 91: 362-363, 2011
8. Satoh T, Ito Y, Miyagishi C, Yokozeki H : Basophils infiltrate skin lesions of eosinophilic pustular folliculitis (Ofuji’s disease) ., Acta Derm Venereol, 91:371-372, 2011
9. Namiki T, Tanemura A, Valencia JC, Coelho SG, Passeron T, Kawaguchi M, Vieira WD, Ishikawa M, Nishijima W, Izumo T, Kaneko Y, Katayama I, Yamaguchi Y, Yin L,Polley EC, Liu H, Kawakami Y, Eishi Y, Takahashi E, Yokozeki H, Hearing VJ. AMPkinase-related kinase NUAK2 affects tumor growth, migration, and clinical outcomeof human melanoma., Proc Natl Acad Sci U S A, 108:6597-602, 2011
10. Hosoya K, Satoh T, Yamamoto Y, Saeki K, Igawa K, Okano M, Moriya T, Imamura O, Nemoto Y, Yokozeki H : Gene silencing of STAT6 with siRNA ameliorates contact hypersensitivity and allergic rhinitis., Allergy, 66:124-131, 2011
11. Matsushima Y, Satoh T, Yamamoto Y, Nakamura M, Yokozeki H. Distinct roles of prostaglandin D2 receptors in chronic skin inflammation., Mol Immunol, 49:304-10, 2011
12. Yamagishi H, Mochizuki Y, Hamakubo T, Obata K, Ugajin T, Sato S, Kawano Y, Minegishi Y, Karasuyama H : Basophil-derived mouse mast cell protease 11 induces microvascular leakage and tissue edema in a mast cell-indepnendent manner., Biochem Biophys Res Commun, 415:709-13, 2011
13. Yamamoto Y, Otani S, Hirai H, Nagata K, Aritake K, Urade Y, Narumiya S, Yokozeki H, Nakamura M, Satoh T: Dual functions of prostaglandin D2 in murine contact hypersensitivity via DP and CRTH2., Am J Pathol, 179:302-314, 2011

2010

1. Kato K, Satoh T, Tanaka T, Ueda N, Yokozeki H : Systemic nickel allergy presenting as papuloerythroderma-like eruptions : Acta Derm Venereol. 90(6):655-6, 2010
2. Satoh T, Shimura C, Miyagishi C, Yokozeki H: Indomethacin-induced reduction in CRTH2 in eosinophilic pustular folliculitis (Ofuji's disease): A proposed mechanism of action : Acta Derm Venereol. 90(1):18-22. 2010
3. Shimura C, Satoh T, Igawa K, Aritake K, Urade Y, Nakamura M, Yokozeki H : Dendritic cells express hematopoietic prostaglandin D synthase and function as a source of prostaglandin D2 in the skin : Am J Pathol. 176(1):227-37. 2010
4. Sugihara T, Okiyama N, Suzuki M, Kohyama K, Matsumoto Y, Miyasaka N, Kohsaka H : Definitive engagement of cytotoxic CD8 T cells in C-protein induced myositis, a murine model of polymyositis : Arthritis and Rheumatism. 62(10):3088-3092. 2010
5. Nishizawa A, Satoh T, Takayama K, Yokozeki H: Hydroa vacciniforme with mucosal involvement and recalcitrant periodontitis and multiple virus re-activators after sun-exposure : Acta Derm Venereol. 90(5):498-501. 2010
6. Hosoya H , Satoh T, Yamamoto Y, Saeki K, Igawa K, Okano M, Moriya T, Imamura O, Nemoto Y, Yokozeki H : Gene silencing of STAT6 with siRNA ameliorates contact hypersensitivity and allergic rhinitis : Allergy. 66(1):124-31. 2010
7. Yukawa M, Satoh T, Takayama K, Yokozeki H : Cutaneous sarcoid reaction in a patient with bladder cancer : Eur J Dermatol. 20(2):235. 2010
8. Wada T, Ishiwata K, Koseki H, Ishikura T, Ugajin T, Ohnuma N, Obata K, Ishikawa R, Yoshikawa S, Mukai K, Kawano Y, Mineg, Yokishi Yozeki H, Watanabe N, Karasuyama H : Selective ablation of basophils in mice reveals their nonredundant role in acquired immunity against ticks : J Clin Invest. 2;120(8):2867-75. 2010
9. Wei J, Ghosh AK, Sargent JL, Komura K, Wu M, Huang QQ, Jain M, Whitfield ML, Feghali-Bostwick C, Varga J : PPARγ downregulation by TGFs in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesis , PLoS One. 5(11):13778, 2010

2009

1. Niwa H,Satoh T,Matsushima Y,Hosoya K,Saeki K,Niki T,Hirashima M,Yokozeki H. Stable form of galectin-9, a Tim-3 ligand,inhibits contact hypersensitivity and psoriatic reactions:A potent therapeutic. Clinical Immunology : (132)184-194. 2009
2. Okiyama N,Sugihara T,Iwakura Y,Yokozeki H,Miyasaka N,Kohsaka H. Therapeutic Effects of Interleukin-6 Blockade in a Murine Model of Polymyositis That Does Not Require Interleukin-17A. ARTHRITIS&RHEUMATISM : 60(8):2505-2512. 2009
3. Shimura C,Satho T,Takayama K,Ykozeki H. Methotrexate-related lymphoproliferative disorder with extensive vascular involvement in a patient with rheumatoid. J Am Acad Dermatol : 61(1):126-129. 2009
4. Tokoro S, Satoh T, Okubo Y, Igawa K, Yokozeki H. Latent Dystrophic Subcutaneous Calcification in Patients with Chronic Venous Insufficiency. Acta Derma Venereol : 89(5):505-508. 2009
5. Ugajin T,kojima T,Mukai K,Obata K,kawano Y,minegishi Y,Eishi Y,yokozeki H,Karasuyama H. Basophils preferentially express mouse mast cell protease 11 among the mast cell tryptase family in contrast to mast cells. Journal of Leukocyte Biology : 86:1417-1425. 2009
6. Tanaka T, Satoh T, Yokozeki H. Dental infection associated with nummular eczema as an overlooked focal infection. J Dermatol. 2009 Aug;36(8):462-5. 2009
7. Yamamoto T, Takayama K, Igawa K, Yamanaka M, Ueno M, Yokozeki H. Eruptive sebaceous hyperplasia in association with chronic renal failure. Clin Exp Dermatol. 2009 Oct;34(7):e244-5. 2009
8. Nishigori K, Yamamoto T, Yokozeki H. Vesiculo-bullous dermatomyositis: report of three cases. Dermatol Online J. 2009 Apr 15;15(4):6. 2009
9. Nishizawa A, Satoh T, Watanabe R, Takayama K, Nakano H, Sawamura D, Yokozeki H. Cowden syndrome: a novel mutation and overlooked glycogenic acanthosis in gingiva. Br J Dermatol. 2009 May;160(5):1116-8. 2009
10. Nishizawa A, Nakano H, Satoh T, Takayama K, Sawamura D, Yokozeki H. Haber's syndrome may be a clinical entity different from Dowling-Degos disease. Br J Dermatol. 2009 Jan;160(1):215-7. 2009
11. Balkow S, Loser K, Krummen M, Higuchi T, Rothoeft T, Apelt J, Tuettenberg A, Weishaupt C, Beissert S, Grabbe S. Dendritic cell activation by combined exposure to anti-CD40 plus interleukin (IL)-12 and IL-18 efficiently stimulates anti-tumor immunity. Experimental Dermatology : 18(1):78-87.2009
12. Igawa K, Satoh T, Yokozeki H. A therapeutic effect of STAT6 decoy oligodeoxynucleotides ointment in atopic dermatitis: A pilot study in adults. Br J Dermatol. 2009 May;160(5):1124-6. 2009
13. Passeron T,Namiki T, Passeron HJ,Le Pape E, Hearing VJ. ForsKolin protects keratinocytes from UVB-induced Apoptosis and increases DNA repair independent of its effects on melanogenesis. J Invest Dermatol. 2009 Jan;129(1):162-6. 2009
14. Passeron T, Valencia JC, Namiki T, Vieira WD, Passeron H, Miyamura Y, Hearing VJ.Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acid.J Clin Invest. 2009 Apr;119(4):954-63.doi: 10.1172/JCI34015. Epub 2009 Mar 9.
15. Zhou G, Dada LA, Wu M, Kelly A, Trejo H, Zhou Q, Varga J, Sznajder JI.Hypoxia-induced alveolar epithelial-mesenchymal transition requires mitochondrial ROS and hypoxia-inducible factor 1.Am J Physiol Lung Cell Mol Physiol. 2009 Dec;297(6):L1120-30.Epub 2009 Oct 2.
16. Wu M, Melichian DS, de la Garza M, Gruner K, Bhattacharyya S, Barr L, Nair A, Shahrara S, Sporn PH, Mustoe TA, Tourtellotte WG, Varga J.Essential roles for early growth response transcription factor Egr-1 in tissue fibrosis and wound healing.Am J Pathol. 2009 Sep;175(3):1041-55. Epub 2009 Aug 13.
17. Bhattacharyya S, Ishida W, Wu M, Wilkes M, Mori Y, Hinchcliff M, Leof E, Varga J.A non-Smad mechanism of fibroblast activation by transforming growth factor-beta via c-Abl and Egr-1: selective modulation by imatinib mesylate.Oncogene. 2009 Mar 12;28(10):1285-97. Epub 2009 Jan 19.
18. Wu M, Melichian DS, Chang E, Warner-Blankenship M, Ghosh AK, Varga J.Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma.Am J Pathol. 2009 Feb;174(2):519-33. Epub 2009 Jan 15.

2008

1. Hamuro J, Higuchi O, Okada K, Ueno M, Iemura S I, Natsume T, Spearman M, Beeson D, Yamanashi Y.Mutations causing DOK7 congenital myasthenia ablate functional motifs in Dok-7. J Biol Chem : 283(9):5518-5524.2008
2. Higuchi T, Satoh T, Yokozeki H. Prurigo in dermatomyositis. Dermatology : 217(4):378-9. 2008
3. Kikuchi A ,Satoh T, Yokozeki H. Primary cutaneous epithelioid Angiosarcoma. Acta Derm Venereol : 88(4):422-3. 2008
4. Matsushita M,Yamamoto T,Yokozeki H. Role of Cytokines and Proteases in Murine Scleroderma. Journal of Medical Dental Sciences : 55(3.4):215-225. 2008
5. Namiki T, Valencia JC, Hall MD, Hearing VJ. A novel approach to enhance antibody sensitivity and specificity by peptide cross-linking. Anai Biochem : 383(2):265-9. 2008
6. Nishizawa A, Nakajima R, Nakano H, Sawamura D, Takayama K, Satoh T, Yokozeki H. A de novo missense mutation in the keratin 13 gene in oral white sponge naevus. Br J Dermatol : 159(4):974-5.2008
7. Nishizawa A, Nakano H, Satoh T, Takayama K, Sawamura D, Yokozeki H. Haber's syndrome may be a clinical entity different from Dowling-Degos disease. Brit J Dermatol : 160(1):215-7. 2008
8. Oiwa M, Satoh T, Watanabe M, Niwa H, Hirai H, Nakamura M, Yokozeki H. CRTH2-dependent, STAT6-independent induction of cedar pollen dermatitis. Clin Exp Allergy : 38(8):1357-66. 2008
9. Okiyama N, Kohsaka H, Ueda N, Satoh T, Katayama I, Nishioka K, Yokozeki H. Seborrheic area erythema as a common skin manifestation in Japanese patients with dermatomyositis. Dermatology : 217(4):374-7. 2008
10. Shimura C, Satoh T, Yokozeki H. Increased expression of hematopoietic prostaglandin D synthase in CCR4-positive T cells from patients with atopic dermatitis. Acta Derm Venereol : 88(5):506-8. 2008
11. Takayama K, Satoh T, Hayashi M, Yokozeki H. Psoriatic skin lesions induced by BCG vaccination. Acta Derm Venereol : 88(6):621-2. 2008
12. Takayama K, Satoh T, Maruyama R, Yokozeki H. Dialysis-related Amyloidosis on the buttocks. Acta Derm Venereol : 88(1):72-73. 2008
13. Takayama K, Satoh T, Yokozeki H. Papular granuloma annulare with subcutaneous granulomatous reaction induced by a bee sting. Acta Derm Venereol : 88(5):519-20. 2008
14. Watanabe M, Satoh T, Yamamoto Y, Kanai Y, Karasuyama H, Yokozeki H. Overproduction of IgE induces macrophage-derived chemokine (CCL22) secretion from basophils. J Immunol : 181(8):5653-9. 2008
15. Yamazaki S, Dudziak D, Heidkamp GF, Fiorese C, Bonito AJ, Inaba K, Nussenzweig MC, Steinman RM. CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells. J Immunol : 181(10):6923-33. 2008

2007

1. Cheong C, Idoyaga J, Do Y, Pack M, Park SH, Lee H, Kang YS, Choi JH, Kim JY, Bonito A, Inaba K, Yamazaki S, Steinman RM, Park CG. Production of monoclonal antibodies that recognize the extracellular domain of mouse langerin/CD207. J Immunol Methods. 31;324(1-2):48-62. 2007
2. Igawa K, Nishioka K, Yokozeki H. Odontogenic focal infection could be partly involved in the pathogenesis of atopic dermatitis as exacerbating factor. Int J Dermatol, 46(4):376-9. 2007.
3. Ishida M, Miyamoto M, Naitoh S, Tatsuda D, Hasegawa T, Nemoto T, Yokozeki H, Nishioka K, Matsukage A, Ohki M, Ohta T. The SYT-SSX fusion protein down-regulates the cell proliferation regulator COM1 in t(x;18) synovial sarcoma. Mol Cell Biol, 27(4):1348-55. 2007.
4. Kenmochi A, Satoh T, Igawa K, Yokozeki H. Silica granuloma induced by indwelling catheter. J Am Acad Dermatol. (2 Suppl) S54-5. 2007
5. Nishizawa A, Toyomaki Y, Nakano A, Takeuchi S, Matsuzaki Y, Takeda H, Kaneko T, Mitsuhashi Y, Nakano H. A novel H1 domain mutation in the keratin 2 gene in a Japanese family with ichthyosis bullosa of Siemens. Br J Dermatol. 156(5):1042-4. 2007
6. Takehara Y, Igawa K, Satoh T, Yokozeki H. Psoriasiform eruption induced by alpha1-adrenergic blocker, urapidil. J Eur Acad Dermatol Venereol, 21(4):577-8. 2007.
7. Tanaka T, Satoh T, Yokozeki H. Allergic contact dermatitis from luliconazole: implication of the dithioacetal structure. Acta Derm Venereol, 87(3):271-2. 2007.
8. Ueda N, Satoh T, Yamamoto T, Yokozeki H. Nodular cystic fat necrosis in Heerfordt's syndrome. J Eur Acad Dermatol Venereol. 21(5):708-9. 2007.
9. Ugajin T, Yahara H, Moriyama Y, Sato T, Nishioka K, Yokozeki H. Two siblings with neonatal pemphigus vulgaris associated with mild maternal disease. Br J Dermatol, 157(1):192-4. 2007.
10. Yamamoto T, Yokozeki H. Increased expression of vascular endothelial growth factor and its receptor, Flt-1, in glomeruloid haemangioma associated with Crow-Fukase syndrome. J Eur Acad Dermatol Venereol, 21(3):417-9. 2007.
11. Yamamoto T, Yokozeki H. Yellow nails under bucillamine therapy for rheumatoid arthritis: a report of two cases. Rheumatol Int, 27(6):603-4. 2007.
12. Yamamoto T, Yokozeki H, Nishioka K. Fas-and FasL-deficient mice are resistant to the induction of bleomycin-induced scleroderma. Arch Dermatol Res, 298(9):465-8. 2007.
13. Yamamoto T, Yokozeki H. Persistent bilateral hyperpigmentation caused by local stem cell factor injection. J Eur Acad Dermatol Venereol, 21(4):576-7. 2007.
14. Yamamoto T, Yokozeki H, Tsuboi R. Koebner's phenomenon associated with palmoplantar pustulosis. J Eur Acad Drmatol Venereol. 21(7):990-2. 2007
15. Yamazaki S, Bonito AJ, Spisek R, Dhodapkar M, Inaba K, Steinman RM. Dendritic cells are specialized accessory cells along with TGF-{beta} for the differentiation of Foxp3+ CD4+ regulatory T cells from peripheral Foxp3- precursors. Blood. 2007
16. Yokozeki H, Satoh T, Katayama I, Nishioka K. Airborne contact dermatitis due to Japanese cedar pollen. Contact Dermatitis, 56(4):224-8. 2007.
17. Yukawa M, Satoh T, Higuchi T, Yokozeki H. Spiny keratoderma of the palms successfully treated with topical tacalcitol. Acta Derm Venereol, 87(2):172-4. 2007.
18. Varga G, Balkow S, Wild MK, Stadtbaeumer A, Krummen M, Rothoeft T, Higuchi T, Beissert S, Wethmar K, Scharffetter-Kochanek K, Vestweber D, Grabbe S. Active MAC-1 (CD11b/CD18) on DCs inhibits full T-cell activation. Blood. 15;109(2):661-9. 2007
19. Yahara H, Satoh T, Hashimoto T, Yokozeki H. Transient macular erythema with eosinophilia in a patient carrying the FIP1L1-PDGFRA fusion gene. Br J Dermatol. 2007

2006

1. Charalambous A, Oks M, Nchinda G, Yamazaki S, Steinman RM. Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin.J Immunol. 2006 Dec 15;177(12):8410-21.
2. Chen SJ, Ning H, Ishida W, Sodin-Semrl S, Takagawa S, Mori Y, Varga J. The early-immediate gene EGR-1 is induced by transforming growth factor-beta and mediates stimulation of collagen gene expression. J Biol Chem. 2006 Jul 28;281(30):21183-97.
3. Ferreira AM, Takagawa S, Fresco R, Zhu X, Varga J, DiPietro LA. R Diminished induction of skin fibrosis in mice with MCP-1 deficiency. J Invest Dermatol. 2006 Aug;126(8):1900-8.
4. Igawa K, Endo H, Yokozeki H, Nishioka K, Kawaguchi T. Alopecia in Vogt-Koyanagi-Harada syndrome. J Eur Acad Dermatol Venereol. 2006 Feb;20(2):236-8.
5. Igawa K, Satoh T, Hirashima M, Yokozeki H.:Regulatory mechanisms of galectin-9 and eotaxin-3 synthesis in epidermal keratinocytes: possible involvement of galectin-9 in dermal eosinophilia of Th1-polarized skin inflammation. Allergy. 2006 Dec;61(12):1385-91.
6. Ishida M, Miyamoto M, Naitoh S, Tatsuda D, Hasegawa T, Nemoto T, Yokozeki H, Nishioka K, Matsukage A, Ohki M, Ohta T. :The SYT-SSX fusion protein down-regulates the cell proliferation regulator COM1 in t(x;18) synovial sarcoma. Mol Cell Biol. 2006
7. Kenmochi A, Satoh T, Fukuyama K, Yokozeki H.:Pacinian neuroma. J Eur Acad Dermatol Venereol. 2006
8. Komori K, Hasegawa A, Kurihara K, Honda T, Yokozeki H, Masuda T, Kannagi M.:Reduction of human T-cell leukemia virus type 1 (HTLV-1) proviral loads in rats orally infected with HTLV-1 by reimmunization with HTLV-1-infected cells. J Virol. 2006 Aug;80(15):7375-81.
9. Loser K, Balkow S, Higuchi T, Apelt J, Kuhn A, Luger TA, Beissert S. FK506 controls CD40L-induced systemic autoimmunity in mice. J Invest Dermatol. 2006 Jun;126(6):1307-15.
10. Miyazaki Y, Satoh T, Nishioka K, Yokozeki H.:STAT-6-mediated control of P-selectin by substance P and interleukin-4 in human dermal endothelial cells. Am J Pathol. 2006 Aug;169(2):697-707.
11. Nakamura E, Taniguchi H, Ohtaki N.:A case of crusted scabies with a bullous pemphigoid-like eruption and nail involvement. J Dermatol. 33(3):196-201 2006.
12. Oi M, Sumi K, Yokozeki H. Occupational allergy in office workers caused by the antifouling desk mat. Contact Dermatitis. 2006 Jan;54(1):60-1.
13. Satoh T, Moroi R, Aritake K, Urade Y, Kanai Y, Sumi K, Yokozeki H, Hirai H, Nagata K, Hara T, Utsuyama M, Hirokawa K, Sugamura K, Nishioka K, Nakamura M.:Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor. J Immunol. 2006 Aug 15;177(4):2621-9.
14. Tanaka K, Katoh T, Irimajiri J, Taniguchi H, Yokozeki H.:Preventive effects of various types of footwear and cleaning methods on dermatophyte adhesion. J Dermatol. 2006 Aug;33(8):528-36.
15. Yamamoto T, Yokozeki H.:Yellow nails under bucillamine therapy for rheumatoid arthritis: a report of two cases. Rheumatol Int. 2006
16. Yamamoto T, Yokozeki H, Nishioka K.:Fas- and FasL-deficient mice are resistant to the induction of bleomycin-induced scleroderma. Arch Dermatol Res. 2006
17. Yamamoto T, Nishioka K:Successful treatment with topical tacrolimus for oral psoriasis.J Eur Acad Dermatol Venereol. 2006 Oct;20(9):1137-8.
18. Yamazaki S, Patel M, Harper A, Bonito A, Fukuyama H, Pack M, Tarbell KV, Talmor M, Ravetch JV, Inaba K, Steinman RM. Effective expansion of alloantigen-specific Foxp3+ CD25+ CD4+ regulatory T cells by dendritic cells during the mixed leukocyte reaction. Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2758-63.
19. Yokozeki H, Takayama K, Katayama I, Nishioka K. :Japanese cedar pollen as an exacerbation factor in atopic dermatitis: results of atopy patch testing and histological examination. Acta Derm Venereol. 2006;86(2):148-51.
20. Nishigori K, Igawa K, Sasaki K, Sawada Y.:Toxic shock syndrome with extensive epidermal necrosis in a 9-year-old girl. J Eur Acad Dermatol Venereol. 2006 Nov;20(10):1334-5.
21. Lakos G, Melichian D, Wu M, Varga J.: Increased bleomycin-induced skin fibrosis in mice lacking the Th1-specific transcription factor T-bet. Pathobiology. 2006;73(5):224-37.
Review
1. Tarbell KV, Yamazaki S, Steinman RM. The interactions of dendritic cells with antigen-specific, regulatory T cells that suppress autoimmunity. Semin Immunol. 2006 Apr;18(2):93-102. Epub 2006 Feb 15. Review.
2. Yamamoto T, Nishioka K:Flagellate erythema. Int J Dermatol. 2006 May;45(5):627-31. Review.
3. Yamamoto T, Yokozeki H, Nishioka K.:Psoriasis under haemodialysis. J Eur Acad Dermatol Venereol. 2006 Oct;20(9):1139-40.
4. Yamamoto T.:Bleomycin and the skin. Br J Dermatol. 155(5):869-75. 2006. Review.
5. Yamazaki S, Inaba K, Tarbell KV, Steinman RM. Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity. Immunol Rev. 2006 Aug;212:314-29. Review.

2005

1. Yokozeki H, Takayama K, Katayama I, Nishioka K: Japanese cedar pollen as a exacerbation factor of atopic dermatitis: results of atopy patch testing and histological examinations. Acta Dermato Venereologica. 2006;86(2):148-51.
2. Igawa K, Endo , Yokozeki H, Nishioka K Kawaguchi T:Alopecia in Vogt-Koyanagi-Harada syndrome. J Eur Acad Dermatol Venereol. 2006 Feb;20(2):236-8.
3. Igawa K, Matsunaga T, Yokozeki H, Nishioka K:Erythrodermic drug eruption due to roxatidine acetate hydrochrolide. Clin Exp Dermatol. 2005; 30(3):304-5
4. Yokozeki H., Niiyama S., Nishioka K.: Twenty-nail dystrophy (trachynychia) caused by lichen planus in a patient with gold allergy. Br J Dermatol. 2005; 152(5):1087-9
5. Yokozeki H, Ueno M, Komori K, Nishioka K: Multiple linear erythema dyschromicum perstans (Ashy dermatosis) in the line of Blaschko. Dermatology. 2005; 210(4) :356-357
6. Ugajin T, Satoh T, Yokozeki H, Nishioka K: Mycosis fungoides presenting as pigmented purpuric eruption. Eur J Dermatol. 2005; 15(6):489-91
7. Satoh T, Kanai Y, Wu MH, Yokozeki H, Kannagi R, Lowe JB, Nishioka K: Synthesis of alpha (1,3) fucosyltransferases IV- and VII-dependent eosinophil selection ligand and recruitment to the skin. Am J Pathol. 2005; 167(3):787-96
8. Mukai K, Matsuoka K, Taya C, Suzuki H, Yokozeki H, Nishioka K, Hirokawa K, Etori M, Yamashita M, Kubota T, Minegishi Y, Yonekawa H, Karasuyama H: Basophils play a critical role in the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells. Immunity. 2005;23(3):191-202
9. Yamamoto T, Yokozeki H, Nishioka K:Clinical analysis of 21 patients with psoriasis arthropathy. J Dermatol. 2005;32(2):84-90
10. Oi M, Satoh T, Yokozeki H, Nishioka K:Infectious urticaria with purpura: a mild subtype of urticarial vasculitis? Acta Derm Venereol. 2005;85(2):167-70
11. Yamamoto T, Sawada Y, Katayama I, Nishioka K: Nodular scleroderma:increased expression of connective tissue growth fator. Dermatology. 2005;211(3):218-23
12. Sano T, Katoh T, Nishioka K: Culturing dermatophytes rapidly from each toe web by fingertip. J Dermatol. 2005;32(2):102-7
13. Matsushita M, Yamamoto T, Nishioka K:Plasminogen activator inhibitor-1 is elevated, but not essential, in the development of bleomycin-induced murine scleroderma. Clin Exp Immunol. 2005;139(3):429-38
14. Nishimoto N, Kanakura Y, Aozasa K, Johkoh T, Nakamura M, Nakano S, Nakano N, Ikeda Y, Sasaki T, Nishioka K, Hara M, Taguchi H, Kimura Y, Kato Y, Asaoku H, Kumagai S, Kodama F, Nakahara H, Hagihara K, Yoshizaki K, Kishimoto T: Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood. 2005;106(8):2627-32
15. Okiyama N, Stoh T, Yokozeki H, Nishioka K: Squamous cell carinoma arising from lichen planus of nail bed. J Am Acad Dermatol. 2005; 53(5):908-9
16. Okiyama N, Yamamoto T, Watanabe K, Yokozeki H, Nishioka K:Juvenile dermatomyositis in association with 22q11.2 deletion sydrome. Br J Dermatol. 2005;152(6)1370-2
17. Yamamoto T, Nishioka K: Increased expression of p53 and p21(waf1/Cip1) in the lesional skin of bleomycin-induced scleroderma. Arch Dermatol Res. 2005;296(11):509-13
18. Bhattacharyya S, Ghosh AK, Pannu J, Mori Y, Takagawa S, Chen G, Trojanowska M, Gilliam AC, Varga J: Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta. Arthritis Rheum. 2005;52(4):1248-58
19. Namiki T, Yanagawa S, Izumo T, Ishikawa M, Tachibana M, Kawakami Y, Yokozeki H, Nishioka K, Kaneko Y: Genomic alterations in primary cutaneous melanomas detected by comparative genomic hybridization with laser capture or manual microdissection: 6p gains may predict poor outcome. Cancer Genet Cytogenet. 2005; 157(1):1-11
Review
1. Yokozeki H:Contact dermatitis. Nippon Rinsho. 2005;63(Sup5):131-135
2. Nishioka K:Mechanism to induce intractable condition of atopic dermatitis. Nippon Rinsyo. 2005;63(Sup5):91-5
3. Yamamoto T, Nishioka K:Celler and molecular mechanisms of bleomycin-induced murine scleroderma:current update and future perspective. Exp Dermatol. 2005:14(2):81-95
4. Steinman RM, Bonifaz L, Fujii S, Liu K, Bonnyay D, Yamazaki S, Pack M, Hawiger D, Iyoda T, Inaba K, Nussenzweing MC: The innate functions of dendritic cells in peripheral lymphoid tissues. Adv Exp Med Biol.2005;560:83-97

2004

1. Sumi K, Yokozeki H, Wu M-H, Satoh T, Kaneda Y, Takeda K, Akira S, Nishioka K: In vivo transfection of a cis element “Decoy” against signal transducers and activators of the transcription 6 (STAT6) binding site ameliorates the response of contact hypersensitivity. Gene Ther. 2004; (11): 1763-1771
2. Yokozeki H, Wu M-H, Sumi K, Awad S, Satoh T, Katayama I, Takeda K, Akira S, Kaneda Y, Nishioka K: In vivo transfection of a cis element "Decoy" against signal transducers and activators of transcription 6 (STAT6) binding site ameliorates IgE-mediated late-phase reaction in an atopic dermatitis mouse model. Gene Ther. 2004; (11)1753-1762
3. Yougnak-Piboonratanakit P, Tsushima F, Otsuki N, Igarashi H, Machida U, Iwai H, Takahashi Y, Omura K, Yokozeki H, Azuma M.: The expression of B7-H1 on keratinocytes in chronic inflammatory mucocutaneous disease and its regulatory role. Immunol Lett. 2004; 94:215-222
4. Sakashita S, Takayama K, Nishioka K, Katoh T:Taste disorders in healthy "carriers" and "non-carriers" of Candida albicans and in patients with candidosis of the tongue. J Dermatol. 2004;31(11):890-7
5. Igawa K, Matsunaga T, Nishioka K:Involvement of UV-irradiation in pemphigus foliaceus. J Eur Acad Dermatol Venereol. 2004; 18(2): 216-217
6. Igawa K, Yamamoto T, Nishioka K: Vellous hair in trichoepithelioma papulosum multiplex. Dermatology. 2004; 209:338-339
7. Obi M, Satoh T, Yokozeki H, Nishioka K:Eccrine porocarcinoma with bowenoid changes:Epithelial membrane antigen is not a useful marker for milignant tumours arising from eccrine gland   structures. Acta Derm Venereol. 2004; 84(2): 142-144
8. Wu M-H, Yokozeki H, Takagawa S, Yamamoto T, Satoh T, Kaneda Y, Katayama I, Nishioka K: Hepatocyte growth factor both prevents and ameliorates the symptoms of dermal sclerosis in   a mouse model of sclerodederma. Gene Ther. 2004; 11:170-180
9. Toritsugi M, Satoh T, Higuchi T, Yokozeki H, Nishioka K: A vesiculopustular variant of mycosis fungoides palmaris et plantaris masquerading as palmoplantar pustulosis with nail involvement. J Am Acad Dermatol. 2004; 51:139-141
10. Yamamoto T, Nishioka K:Possible role of apoptosis in the pathogenesis of bleomycin-induced scleroderma. J Invest Dermatol. 2004; 122: 44-50
11. Yamamoto T, Nishioka K: Animal model of sclerotic skin. VI- Evaluation of bleomycin-induced sclerotic skin in nude mice. Arch Dermatol Res. 2004; 295: 453-456
12. Yamamoto T, Nishioka K: Coexistence of psoriasis vulgaris, systemic sclerosis, and annular erythema in association with Sjogren’s syndrome. J Dermatol. 2004; 31: 69-72
13. Yamamoto T, Watanabe K, Nishioka K: Temporomandibular arthritis in a patient with psoriasis vulgaris under systemic etretinate therapy. Dermatology. 2004; 209: 77
14. Yamamoto T, Nishioka K:Severe extra-palmoplantar pustulation associated with palmoplantar pustulosis. J Dermatol. 2004. 31(8): 690-692
15. Yamamoto T, Nakamura S, Nishioka K:Erythema elevatum diutinum associated with Hashimoto's thyroiditis and antiphospholipid antibodies. J Am Acad Dermatol. 2005; 52(1) :165-166
16. Ramirez AM, Takagawa S, Sekosan M, Jafe HA, Varga J, Roman J: Smad3 deficiency ameliorates experimental obliterative bronchiolitis in a heterotopic tracheal transplantation model. Am J Pathol. 2004; 165(4):1223-1232
17. Lakos G, Takagawa S, Varga J:Animal models of scleroderma. Methods Mol Med. 2004; 102:377-393
18. Lakos G, Takagawa S, Chen SJ, Ferreira AM, Han G, Masuda K, Wang XJ, DiPietro LA, Varga J: Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma. Am J Pathol. 2004; 165(1):203-217
19. Tarbell KV, Yamazaki S, Olson K, Toy P, Steinman RM: CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med. 2004; 199(11):1467-1477
20. Matsushita M, Yamamoto T, Nishioka K: Plasminogen activator inhibitor-1 is elevated, but not essential, in the development of bleomycin-induced murine scleroderma. Clin Exp Immunol. 2005; 139(3):429-438
21. Yamamoto T, Nishioka K: Cellular and molecular mechanisms of bleomycin-induced murine scleroderma:current update and future perspective. Exp Dermatol. 2005; 14(2): 81-95
22. Matsushita M, Yamamoto T, Nishioka K: Upregulation of interleukin-13 and its receptor in a murine model of bleomycin-induced scleroderma. Int Arch Allergy Immunol. 2004; 135(4): 348-356
23. Nakamura E, Yamamoto T, Satoh T, Nishioka K: Local recurrence of adult onset Spitz nevus. J Dermatol. 2004; 31(4): 353-355
24. Toritsugi M, Yamamoto T, Nishioka K: Nodular cystic fat necrosis with systemic sclerosis. Eur J Dermatol. 2004; 14(5): 353-355
25. Oi M, Yamamoto T, Nishioka K: Increased expression of TGF-β1 in the sclerotic skin in bleomycin-‘susceptible’ mouse strains. J Med Dent Sci. 2004; 51:7-17

2003

1. Yokozeki H, Wu M-H, Sumi K, Igawa K, Miyazaki Y, Katayama I, Takeda S, Akira S, Nishioka K: Th2 cytokines,IgE and mast cells play a crucial role in the induction of para-phenylenediamine-induced contact hypersensitivity in mice. Clin Exp Immunol. 2003; 132:385-392
2. Higuchi T, Sotoh T, Yokozeki H, Katayama I, Nishioka K: Palpebral edema as a cutaneous manifestation of hyperthyroidism. J Am Acad Dermatol. 2003; 48(4): 617-619
3. Oi M, Satoh T, Yokozeki H, Nishioka K: Detection of immediate-type reaction to the epitope of β-lactam antibiotics by the quick patch test. Br J Dermatol. 2003; 148:182-183
4. Satoh T, Sasaki G, Wu Ming-Hua, Yokozeki H, Katayama I, Nishioka K: Suplatast tosilate inhibits eosinophil production and recruitment into the skin in murine contact sensitivity: Clin Immunol. 2003; 108: 257-262
5. Takagawa S, Gobriella L, Mori Y, Yamamoto T, Nishioka K, John V: Sustained activation of fibroblast transforming growth factor-β/Smad signaling in a murine model of scleroderma. J Invest Dermatol. 2003; 121(1): 41-50
6. Satoh T, Takayama K, Sawada Y, Yokozeki H, Nishioka K.: Chronic nodular prurigo associated with nummuklar eczema: possible involvement of odontogenic infection. Acta Derm Venereol. 2003; 83(108): 376-377
7. Yamamoto T, Matsunaga T, Nishioka K.: Rheumatoid neutrophilic dermatitis, rheumatoid papules and rheumatoid nodules in a patient with seronegative rheumatoid arthritis. J Am Acad Dermatol. 2003; 48: 634-635
8. Yamamoto T, Umeda T, Nishioka K.: Dermatofibroma on the digit:Report of Six Cases. Dermatology. 2003; 207: 79-81
9. Yamamoto T, Nishioka K.: Alteration of the Bcl-2, Bcl-x, Bax Fas and Fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy. Skin Pharmacol Appl Physiol. 2003; 16: 50-58
10. Yamamoto T, Nishioka K.: Role of monocyte chemoattractant protein-1 and its receptor, CCR-2, in the pathogenesis of bleomycin-induced scleroderma. J Invest Dermatol. 2003; 121: 510-516
11. Yamamoto T, Nishioka K: Deep dermatophytosis during topical tacrolimus therapy for psoriasis. Acta Derm Venereol. 2003; 83: 291-292
12. Yamamoto T, Nishioka K: Topical tacrolimus: an effective therapy for facial psoriasis. Eur J Dermatol. 2003; 13: 471-473
13. Yamamoto T, Nishioka K: Association of granzyme-B-positive lymphocytes in regressing plane warts: Dermatology. 2003; 207: 412-414
14. Nakamura S, Nishioka K: Enhanced expression of p16 in seborrhoeic keratosisi; a lesion of accumulated senescent epidermal cells in G1 arrest. Br J Dermatol. 2003; 149: 560-565
15. Igawa K, Nishioka K: Leg ulcer in Kliniefelter's syndrome. J Eur Acad Dermatol Venereol. 2003; 17(1): 62-64
16. Murano K, Koyano T: Estrogen dermatitis that apperared twice in each menstrual period. J Dermatol. 2003; 30(10): 719-722
17. Sumi K, Ymamoto T, Yokozeki H, Nishioka K: Amyloid deposition associated with generalized morphea-like scleroderma. Eur J Dermatol. 2003; 13(5): 509-511
18. Yamamoto I: Home medical care and treatment of decubitus (Bedsores). JMAJ. 2003; 46(6):263-268
19. Maruyama R, Hiruma M, Yamauchi K, Teraguchi S: An epidemiological and clinical study of untreated patients with tinea pedis within a company in Japan. Mycoses. 2003; 46:208-212
20. Kang YS, Yamazaki S, Iyoda T, Pack M, Bruening SA, Kim JY, Takahara K, Inaba K, Steinman RM, Park CG: SIGN-R1, a novel C-type lectin expressed by marginal zone macrophages in spleen, mediates uptake of the polysaccharide dextran. Int Immunol. 2003; 15: 177-186
21. Yamazaki S, Iyoda T, Tarbell K, Olson K, Velinzon K, Inaba K, Steinman RM: Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J Exp Med. 2003; 198:235-247
22. Sakaguchi N, Takahashi T, Hata H, Nomura T, Tagami T, Yamazaki S, Sakihama T, Matsutani T, Negishi I, Nakatsuru S, Sakaguchi S: Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature. 2003; 426:454-460
23. Namiki T, Sakashita A, Kobayashi H, Maseki N, Izumo T, Komada Y, Koizumi S, Shikano T, Kikuta A, Watanabe A, Suzumiya J, Kikuchi M, Kaneko Y: Clinical and genetic characteristics of Japanese Burkitt lymphomas with or without leukemic presentation. Int J Hematol. 2003; 77:490-498
24. Nakamura S, Yokozeki H, Nishioka K:Acute pigmentation due to minomycline therapy in atpic dermatitis. Br J Dermatol. 2003;148(5):1073-4
Review
1. Yamamoto T: Potentioal roles of CCL2/ monocyte chemoattractant protein-1 in the pathogenesis of cutaneous sclerosis. Clin Exp Rheumatoe. 2003; 21:369-375
2. Yamamoto T, Katayama I, Nishioka K: Role of mast cells in dermatofibroma: recent viewpoints into the pathogenesis. Eur J Dermatol. 2003; 13:419-423
3. Yamamoto T: Recent advances in immunological aspects of scleroderma. Recent Res Level Immunology. 2003; 5: 47-56
Book
1. Yamamoto T: Experimental mouse model of scleroderma: induction by bleomycin. Animal models of human inflammatory skin diseases (Edited by Lawrence S.Chan) CRC PRESS. 2003; 535-547

2002

1. Imai K, Yokozeki H, Nishioka K: Kikuchi’s disease (histiocytic necrotizing lymphadenitis) with cutaneous involvement. J Dermatol. 2002; 29(9): 587-592
2. Satoh T, Kaneko M, Wu M-H, Yokozeki H, Nishioka K: Contribution of selection ligands to eosinophil recruitment into the skin of patients with atopic dermatitis. Eur J Immunol. 2002; 32:1274-1281
3. Satoh T, Yokozeki H, Nishioka K: Chronic pigmented purpura associated with odontogenic infection. J Am Acad Dermatol. 2002; 46:942-944
4. Satoh T, Yokozeki H, Nishioka K: Vascular spiders and paper money skin improved by hemodialysis. Dermatology. 2002; 205:73-74
5. Motohashi N, Satoh T, Yokozeki H, Nishioka K: Annular erythema associated with essential thrombocythemia. Acta Derm Venereol. 2002; 82(5): 390
6. Yamamoto T, Nishioka K: Animal model of sclerotic skin V: Increased expression of alpha-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma. Clin Immunol. 2002; 102(1): 77-83
7. Yamamoto T, Nishioka K: Oral psoriasis in patient with hepatitis C virus infection. Eur J Dermatol. 2002; 12(1): 75-76
8. Yamamoto T, Nishioka K: Analysis of the effect of halofuginone on bleomycin-induced scleroderma. Rheumatology. 2002; 41(5): 594-596
9. Yamamoto T, Nishioka K: Psoriasis arthropathy and lymphederma. J Dermatol. 2002; 29(12): 812-814
10. Yamamoto T, Yokozeki H, Nishioka K: Localized involutional lipoatrophy: report of six cases 2002. J Dermatol. 2002; 29(10): 638-643
11. Yamamoto T, Ohi M, Nishioka K: Lymphomatoid papulosis associated with sjogren’s syndrome. J Dermatol. 2002; 29(3): 174-177
12. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S: Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol. 2002; 3:135-142
13. Miyazaki Y, Yamamoto T, Watanabe K, Katayama I, Nishioka K: Alopecia universalis associated with Zumbusch-type generalized pustular psoriasis. Dermatology, 2002; 204:308-309
14. Yamamoto T, Yokozeki H, Nishioka K:Localized involutional lipoatrophy: report of six cases. J Dermatol. 2002;29(10):638-43
15. Awad S, Yokozeki H, Miyazaki Y, Igawa K, Minatohara K, Satoh T, Nishioka K:Glucocorticoids induced the production and gene expression of IL-1alpha through AP-1 and partially NF-kappaB activation in murine epidermal cells. J Med Dent Sci. 2002;49(1):27-35
Review
1. Yamamoto T: Animal model of sclerotic skin induced by bleomycin: a clue to the pathogenesis of and therapy for scleroderma? Clin Immunol. 2002; 102(3): 209-216

2001

1. Igawa K, Yokozeki H, Miyazaki Y, Minatohara K, Satoh T, Katayama I, Nishioka K: Topical glucocorticoids application induced an augmentation in the expression of IL-1α while inhibiting the expression of IL-10 in the epidermis in murine contact hypersenseitivity Clin Exp Allergy. 2001;31(3):485-494
2. Ohki O, Yokozeki H, Katayama I, Nishioka K: Clinical characterisitics of mite allergen specific-lymphocytes stimulation test-positive Japanese cases with adult type atopic dermatitis J Dermatol Sci. 2001; 26:25-35
3. Sasaki K, Yamamoto T, Kishi M, Yokozeki H, Nishioka K: Acute exanthematous pustular drug eruption induced by mexiletine. Eur J Dermatol. 2001;11:469-471
4. Yamamoto T, Sawada Y, Nishioka K: Local expression and systemic release of stem cell factor in systemic sclerosis with diffuse hyperpigmentation. Br J Dermatol. 2001; 144:199-200
5. Yamamoto T, Eckes B, Krieg T: Effect of interleukin-10 on the gene expression of type I collagen, fibronectin, and decorin in human skin fibroblasts:differential regulation by transforming growth factor-β and monocyte chemoattractant protein-1. Biochem Biophys Res Commun. 2001; 281:200-205
6. Yamamoto T, Eckes B, Krieg T: Expression of monocyte chemoattractant protein-1 in the lesional skin of systemic sclerosis. J Dermatol Sci. 2001;26:133-139
7. Yamamoto T, Hartmann K, Eckes B, Krieg T: Role of stem cell factor and monocyte chemoattractant protein-1 in the interaction between fibroblasts and mast cells in fibrosis. J Dermatol Sci. 2001; 26:106-111
8. Yamamoto T, Nishioka K: Animal model of sclerotic skin. IV: Induction of dermal sclerosis by bleomycin is T cell independent. J Invest Dermatol. 2001; 117:999-1001
9. Yamamoto T, Soejima K,Yokozeki H, Katayama I, Koyano T, Nishioka K: Unusual annular erythema associated with myelodysplastic syndrome. Dermatology. 2001; 202:70-72
10. Yamamoto T, Kuroda M, Nishioka K: Increased serum level of vascular endothelial growth factor in Crow-Fukase syndrome. Acta Dermato Venereol. 2001;81:317-318
11. Yamamoto T, Eckes B, Krieg T: High expression and autoinduction of monocyte chemoattractant protein-1 in scleroderma fibroblasts. Eur J Immunol. 2001;31:2936-2941
12. Yamamoto T, Takagawa S, Nishioka K: Mast cell-independent increase of type I collagen expression in experimental scleroderma induced by bleomycin. Arch Dermatol Res. 2001; 293:532-536
13. Yokozeki H, Watanabe K, Igawa K, Miyazaki Y, Katayama I, Nishioka K: Gamma beta T cells assist alpha beta T cells in the adoptive transfer of contact hypersensitivity to para-phenylenediamine. Clin Exp Immunol. 2001; 125:351-359
14. Higuchi T, Aiba Y, Nomura T, Matsuda J, Mochida K, Suzuki M, Kikutani H, Honjo T, Nishioka K, Tsubata T: Cutting edge: Ectopic expression of CD40 ligand on B cells induces lupus-like automimmune disease. J Immunol.2001; 168: 9-12
15. Oka K, Keong CH, Saito F: A case of contact dermatitis due to Nicotinell TTS. Env Dermatol. 2001; 8:172-176
16. Kishimoto H, Furui Y, Nishioka K: B-cell acute lymphoblastic leukemia with alenkemic leukemia cutis. Eur J Dermatol. 2001; 11:151-152
17. Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, Itoh M, Kuniyasu Y, Nomura T, Toda M, Takahashi T: Immunologic tolerance maintained by +25CD CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev. 2001, 182-18-32
18. Sakaguchi S, Takahashi T, Yamazaki S, Kuniyasu Y, Itoh M, Sakaguchi N, Shimizu J: Immunologic self tolerance maintained by T-cell-mediated control of self-reactive T cells: implications for autoimmunity and tumor immunity. Microbes Infect. 2001; 3: 911-918
19. Kumon K, Koyabashi H, Namiki T, Tsunematsu Y, Miyauchi J, Kikuta A, Horikishi Y, Komada Y, Hatae Y, Eguchi H, Kaneko Y: Frequent increase of DNA copy number in the 2q24 chromosomal region and its association with a poor clinical outcome in hepatoblastoma: cytogenetic and comparative genomic hybridization analysis. Jpn J Cancer Res. 2001; 92: 854-862
20. Nakadate H, Yokomori K, Watanabe N, Tsuchiya T, Namiki T, Kobayashi H, Suita S, Tsunematsu Y, Horikoshi Y, Hatae Y, Endo M, Komada Y, Eguchi H, Toyoda Y, Kikuta A, Kobayashi R, Kaneko Y: Mutations/ deletions of the WT1 gene, loss of heterozygosity on chromosome arms 11p and 11q, chromosome ploidy and histology in Wilms' tumors in Japan. Int J Cancer. 2001; 94: 396-400
Review
1. Katayama I, Bae SJ, Hamasaki Y, Igawa K, Miyazaki Y, Yokozeki H, Nishioka K:Stress response, tachykinin and cutaneous inflammation. J Investig Dermatol Symp Proc. 2001;6(1):81-6

2000

1. Yokozeki H, Ghoreishi M, Takagawa S, Takayama K, Satoh T, Katayama I, Takeda K, Akira S, Nishioka K : Signal transducer and activator of transcription 6 Is essential in the induction of Contact Hypersensitivity. J Exp Med. 2000 ; 191(6): 995-1004
2. Sasaki G, Satoh T, Yokozeki H, Katayama I, Nishioka K : Regulation of cyclophosphamide-induced eosinophilia in contact sensitivity: Functional roles of interleukin-5-producing CD4+lymphocytes. Cell Immunol. 2000 ; 203:124-133
3. Satoh T, Yokozeki H, Nishioka K : Pathogenic roles of eosinophils in guinea-pig contact sensitivity : regulation of dermal eosinophilia with remotely administered IL-5. Clin Exp Immunol. 2000; 122:300-307
4. Yamamoto T, Takagawa S, Kuroda M, Nishioka K :Effect of interferon-γon experimental scleroderma induced by bleomycin. Arch Dermatol Res. 2000; 292:362-365
5. Yamamoto T, Hartmann K, Eckes B, Krieg T : Mast cells enhance contraction of three-dimensional collagen lattices by fibroblasts by cell-cell interaction: role of stem cell factor/c-kit. Immunology. 2000; 99:435-439
6. Yamamoto T, Yokoyama A : Eosinophil infiltration in the sclerodermoid cutaneous metastasis of a breast cancer. J Dermatol. 2000; 27(8):552-553
7. Yamamoto T, Eckes B, Mauch C, Hartmann K, Krieg T, Hartmann K : Eosinophil infiltration in the sclerodermoid cutaneous metastasis of a breast cancer. J Immunol. 2000 ; 164:6174-6179
8. Yamamoto T, Matsuuchi M, Irimajiri J, Otoyama K, Nishioka K : Topical anthralin for psoriasis vulgaris: Evaluation of 70 Japanese patients. J Dermatol. 2000; 27:482-485
9. Yamamoto T, Katayama I, Nishioka K : A rare association of systemic sclerosisi with psoriasis vulgaris. J Dermatol. 2000; 27:346-349
10. Yamamoto T, Nishioka K : Vitiligo vulgaris associated with hepatitis C virus. J Dermatol. 2000; 27:415-417
11. Yamamoto T, Otoyama K, Nishioka K : Unusual annular pustular psoriasis in a patient with type C hepatitis. J Dermatol. 2000; 27:802-803
12. Yamamoto T, Kuroda M, Nishioka K: Animal model of sclerotic skin III :Histopathological comparison of bleomycin-induced scleroderma in various mice strains. Arch Dermatol Res. 2000; 292(11):535-541
13. Yamamoto T, Eckes B, Krieg T : Bleomycin increases steady-state level of type I collagen, fibronectin and decorin mRNAs in human skin fibroblasts. Arch Dermatol Res. 2000; 292(11):556-56
14. Yamamoto T, Katayama I, Nishioka K: Possible contribution of stem cell factor in psoriasis vulgaris. J Dermatol Sci. 2000; 24:171-176
15. Yamamoto T, Umeda T, Nishioka K : Immunohistological distribution of stem cell factor and kit receptor in angiosarcoma. Acta Derm venereol. 2000; 80:443-445
16. Yamamoto T, Nishioka K : Topical tacrolimus is effective for facial lesions of psoriasis. Acta Derm venereol. 2000 ; 80:451
17. Imai K, Tatsumi H, Katayama Y : Mechanosenitive chloride channels on the growth cones of cultured rat dorsal root ganglion neurons. Neuroscience. 2000 ; 97(2):347-355
18. Ghoreishi M, Yokozeki H, Ming Hua, Nishioka K : Expression of 27KD, 65KD and 72/73KD heat shock protein in atopic dermatitis : Comparison with those in normal skin and contact dermatitis. J Dermatol. 2000 ; 27:370-379
19. Yoshida T, Higuchi H, Hagiyama H, Strasser A, Nishioka K, Tsubata T:Rapid B cell apoptosis induced by antigen receptor ligation does not require Fas(CD95/APO-1),the adaptor protein FADD/MORT1 or CrmA-sensitive caspases but is defective in both MRL-+/+ and MRL-lpr/lpr mice. Int Immunol. 2000 ; 12(4):517-526
20. Miyazaki Y, Yokozeki H, Awad S, Igawa K, Minatohara K, Satoh T, Katayama I, Takeda K, Nishioka K : Glucocorticoid augments the chemically induced production and gene expression of interleukin-1αthrough NF-κB and AP-1 activation in murine epidermal cells. J Invest Dermatol. 2000 ; 115(4):746-752
21. Takagawa S, Satoh T, Yokozeki H, Nishioka K : Multipule minute digitate hyperkeratoses. Brit J Dermatol. 2000 ; 142:1044-1046
22. Ishida R, Murata Y, Sawada Y, Nishioka K, Shibuya H: Thallium-201 myocardial SPET in patients with collagen disease. Nucl Med Commun. 2000; 21:729-734
23. Kishimoto H, Nagata S, Yamada A, Nishioka K: Rudimentary meningocele presenting with an annular alopecia. Eur J Dermatol. 2000; 10:215-216
24. Watanabe K, Taniguchi H, Katoh T: Adhesion of dermatophytes to healthy feet and its simple treatment. Mycoses. 2000; 43:45-50
25. Takahashi T, Tagami T, Yamazaki S, Uede T, Shimizu J, Sakaguchi N, Mak TW, Sakaguchi S: Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med. 2000; 192:303-310
26. Tsuchiya T, Sekine K, Hinohara S, Namiki T, Nobori T, Kaneko Y: Analysis of the p16INK4, p14ARF, p15, TP53 and MDM2 genes and their prognostic implications in osteosarcoma and Ewing sarcoma. Cancer Genet Cytogenet. 2000; 120:91-98
Review
1. Yokozeki H : Drug eruptions on the elderly. Asian Medical J. 2000; 43(9):453-458
2. Ghoreishi M : Heat shock proteins in the pathogenesis of inflammatory skin diseases. J of Med Dent Sci . 2000; 47(2):143-150
3. Yokozeki H, Nishioka K: Allergic contact dermatitis. Ryoikibetsu Shokogun Shirizu. 2000;(31):551-3

pagetop